By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Regulus Therapeutics, Inc. 

1896 Rutherford Road

Carlsbad  California  92008-7208  U.S.A.
Phone: 888-734-8587 Fax: n/a


SEARCH JOBS



Segment
Start Up





Company News
Regulus Therapeutics, Inc. (RGLS) To Present Late-Breaking, Expanded RG-101 Data Set For The Treatment Of HCV At The International Liver Congress 2015 (ILC 2015) 4/9/2015 8:06:03 AM
Regulus Therapeutics, Inc. (RGLS) Release: RG-125 (AZD4076), A microRNA Therapeutic Targeting Microrna-103/107 For The Treatment Of NASH In Patients With Type 2 Diabetes/Pre-Diabetes, Selected As Clinical Candidate By Astrazeneca 4/8/2015 6:44:04 AM
Regulus Therapeutics, Inc. (RGLS) Receives Orphan Medicinal Product Designation From The European Commission (EC) For RG-012, A Microrna Therapeutic In Development For The Treatment Of Alport Syndrome 3/25/2015 6:43:15 AM
Regulus Therapeutics, Inc. (RGLS) To Present At Cowen and Company 35th Annual Healthcare Conference 2/27/2015 9:42:49 AM
Regulus Therapeutics, Inc. (RGLS) To Present At 2015 RBC Capital Markets' Healthcare Conference 2/20/2015 8:42:34 AM
Regulus Therapeutics, Inc. (RGLS) Reports Fourth Quarter And Year-End 2014 Financial Results And Recent Highlights 2/19/2015 11:46:04 AM
Regulus Therapeutics, Inc. (RGLS) Announces Timing For Fourth Quarter And Year-End 2014 Financial Results Webcast And Conference Call 2/13/2015 6:56:47 AM
Regulus Therapeutics, Inc. (RGLS) To Ring The Nasdaq Stock Market Closing Bell 2/9/2015 9:47:10 AM
Regulus Therapeutics, Inc. (RGLS) Release: All HCV Patients Treated with a Single SC Administration Of 4 Mg/Kg Of RG-101 Responded With Mean Viral Load Reduction Of 4.8 Log10 At Day 29 And 9/14 Patients Are Below The Limit Of Quantification At Day 57 2/9/2015 8:58:18 AM
Regulus Therapeutics, Inc. (RGLS) To Present At Two Upcoming Investor Conferences 2/3/2015 11:46:56 AM
12345678910...
//-->